Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature
JM Berthelot, M De Bandt, P Goupille, E Solau-Gervais… - Joint Bone Spine, 2009 - Elsevier
OBJECTIVE: To report on the outcome of 15 cases of pregnancies in women treated with
anti-TNF drugs during conception or pregnancy METHODS: French rheumatologists …
anti-TNF drugs during conception or pregnancy METHODS: French rheumatologists …
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three‐year …
F Tubach, D Salmon, P Ravaud… - … : Official Journal of …, 2009 - Wiley Online Library
Objective Tuberculosis (TB) is associated with anti–tumor necrosis factor (anti‐TNF)
monoclonal antibody (mAb) therapy, but whether this association is drug‐specific remains a …
monoclonal antibody (mAb) therapy, but whether this association is drug‐specific remains a …
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French autoimmunity and rituximab registry
Objective A number of open‐label studies have suggested the potential benefit of rituximab
(RTX) in systemic lupus erythematosus (SLE). However, in 2 recent randomized controlled …
(RTX) in systemic lupus erythematosus (SLE). However, in 2 recent randomized controlled …
Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
YM Pers, C Fortunet, E Constant, J Lambert… - …, 2014 - academic.oup.com
Objective. The objective of this study was to identify predictors of response and remission to
tocilizumab (TCZ) in RA patients seen in daily routine clinical practice. Methods. The efficacy …
tocilizumab (TCZ) in RA patients seen in daily routine clinical practice. Methods. The efficacy …
Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
Objectives To evaluate the prevalence of late-onset neutropenia and its complications in
patients treated with rituximab (RTX) for rheumatoid arthritis (RA) and other autoimmune …
patients treated with rituximab (RTX) for rheumatoid arthritis (RA) and other autoimmune …
Apolipoprotein AI and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis
C Trocmé, H Marotte, A Baillet… - Annals of the …, 2009 - ard.bmj.com
Objectives: The use of biologicals such as infliximab has dramatically improved the
treatment of rheumatoid arthritis (RA). However, factors predictive of therapeutic response …
treatment of rheumatoid arthritis (RA). However, factors predictive of therapeutic response …
Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis
YM Pers, R Schaub, E Constant, J Lambert… - Joint Bone Spine, 2015 - Elsevier
Objective To assess the safety and efficacy of tocilizumab (TCZ) in elderly (≥ 65 years)
rheumatoid arthritis (RA) patients treated in daily practice. Methods We conducted a …
rheumatoid arthritis (RA) patients treated in daily practice. Methods We conducted a …
Response to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient
YM Pers, M Godfrin-Valnet, J Lambert… - The Journal of …, 2015 - jrheum.org
Objective. To assess the relationship between the body mass index (BMI) and the efficacy of
tocilizumab (TCZ) in patients with rheumatoid arthritis (RA). Methods. We conducted a …
tocilizumab (TCZ) in patients with rheumatoid arthritis (RA). Methods. We conducted a …
[HTML][HTML] Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study
H Bauer, C Luxembourger, JE Gottenberg, S Fournier… - Medicine, 2015 - journals.lww.com
The clinical presentation and outcome of hepatitis E virus (HEV) infection in inflammatory
rheumatic diseases are unknown. We aimed to investigate the severity of acute HEV …
rheumatic diseases are unknown. We aimed to investigate the severity of acute HEV …
High prevalence of dementia in women with osteoporosis
A Amouzougan, L Lafaie, H Marotte, D Dẻnariẻ… - Joint bone spine, 2017 - Elsevier
Introduction Alzheimer's disease or other Dementias (ADD) and postmenopausal
osteoporosis are two major public health problems with a huge impact on mortality. Here, we …
osteoporosis are two major public health problems with a huge impact on mortality. Here, we …